Improving testing for hepatitis B before treatment with rituximab

AIMS/OBJECTIVES/BACKGROUND: Individuals with current or previous infection with the hepatitis B virus (HBV) can experience viral reactivation when treated with immunosuppression. Rituximab, an anti-CD20 antibody used to treat many diseases, has potent immunosuppressant effects with a high risk of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyson, Jessica K., Jopson, Laura, Ng, Sarah, Lowery, Matthew, Harwood, Jayne, Waugh, Sheila, Valappil, Manoj, McPherson, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2016
Materias:
Original Articles: Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010281/
https://www.ncbi.nlm.nih.gov/pubmed/27388147
http://dx.doi.org/10.1097/MEG.0000000000000689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010281/
https://www.ncbi.nlm.nih.gov/pubmed/27388147
http://dx.doi.org/10.1097/MEG.0000000000000689

Ejemplares similares